Keywords: Bydureon®; Byetta®; exenatide; GLP-1 agonists; tachycardia; nodule; adverse reaction; nausea; gastrointestinal;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Exenatide; Emulsion electrospray; PLGA microspheres; Thermosensitive hydrogel; Release rate; Bioactivity;
Keywords: Incretin; GLP-1; Exenatide; DPP-IV; Sitagliptin; Atherosclerosis; Endothelial cell function; Incretin therapy; Vascular inflammation; Cardiovascular diseases;
Keywords: Aptides; Exenatide; Human serum albumin; Fusion peptide; GLP-1; Type 2 diabetes;
Keywords: Type-2 diabetes; Exenatide; Intra-abdominal fat; Inflammatory factors;
Keywords: Parkinson's disease; Rotenone; Glucagon-like peptide 1; Exenatide; Tumor necrosis factor alpha;
Keywords: Exenatide; GLP-1; Glucagon-like peptide-1 receptor agonist; Type 2 diabetes; Long-term efficacy and safety Pooled analysis;
Keywords: diabetes mellitus; exenatide; glycemic control; liraglutide; observational study; weight;
Keywords: delayed-action preparations; exenatide; pharmacology; type 2 diabetes;
Keywords: Asian race; Exenatide; Glycemic control; Post-prandial glucose; Type 2 diabetes;
Keywords: Exenatide; Metformin; Combination therapy; Type 2 diabetes mellitus; Gender difference;
Keywords: GLUT; Glucose transporter; T1DM; Type-1 diabetes mellitus; T2DM; Type-2 diabetes mellitus; PKB/Akt; protein kinase B; GSK-3; glycogen synthase kinase-3; PGC-1α; peroxisome proliferator-activated receptor gamma coactivator-1α; FOXO; forkhead box O; VLDL;
Keywords: Diabetic peripheral neuropathy; Cardiovascular autonomic neuropathy; GLP-1receptor agonist; Exenatide; Glargine; Clinical trial;
Keywords: Feline; Exenatide; Incretin; Diabetes; Insulin; Glucagon;
Keywords: NPs; nanoparticles; SC; subcutaneous/ly; STMP; sodium trimetaphosphate; MPs; microparticles; Eudragit L; Eudragit® L100-55; HPMC; hydroxypropylmethylcellulose; GLP-1; glucagon-like peptide-1; BSA; bovine serum albumin; DDW; bi-distilled water; Cryo-TEM;
Keywords: albiglutide; dulaglutide; exenatide; GLP-1 receptor agonists; liraglutide; lixisenatide;
Keywords: Apomorphine-induced stereotypic behavior test; Exenatide; Nonalcoholic fatty liver; Psychosis
Keywords: Exenatide; Exenatide once-weekly; GLP-1 receptor agonists; Liraglutide; Lixisenatide; Type 2 diabetes
Keywords: Exenatide; Type 2 diabetes; Long-acting insulin analogs; Glargine; Detemir; Retrospective cohort; Pharmacoepidemiology; Veterans;
Keywords: Exenatide; Exendin 4; GLP-1; Parkinson's disease; Clinical trial design;
Keywords: Exenatide; Obesity; Taste;
Keywords: Macrophage; Exenatide; Diabetes; Inflammation; Atherosclerosis
Long-term effects of GLP-1 receptor agonists in type 2 diabetic patients: A retrospective real-life study in 131 patients
Keywords: Type 2 diabetes; Treatment; GLP-1 receptor agonists; Exenatide; Liraglutide;
Exenatide modulates metalloproteinase expression in human cardiac smooth muscle cells via the inhibition of Akt signaling pathway
Keywords: Atherosclerosis; Incretins; Exenatide; Matrix metalloproteinases; Human coronary artery smooth muscle cells; Exendin-4;
Battle of GLP-1 delivery technologies
Keywords: GLP-1 receptor agonist; Exenatide; Peptide delivery; Half-life; Pharmacokinetics; Fatty acid conjugate; Albumin fusion; Fc fusion;
Effect of size on the in vitro/in vivo drug release and degradation of exenatide-loaded PLGA microspheres
Keywords: PLGA microspheres; Exenatide; Particle size; Drug release; Degradation;
Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease
Keywords: Parkinson's disease; Exenatide; Glucagon-like peptide-1 agonist; Insulin resistance; Neuroprotection;
Les incrétines
Keywords: analogue du GLP-1; antidiabétique oral; exénatide; gliptine; incrétine; inhibiteur de DPP-4; liraglutide; DPP-4 inhibitor; exenatide; gliptin; GLP-1 analogue; incretin; liraglutide; oral antidiabetic;
Short term monotherapy with exenatide is superior to metformin in weight loss, improving insulin resistance and inflammation in Chinese overweight/obese PCOS women
Keywords: Exenatide; GLP-1 receptor agonist; Polycystic ovary syndrome; Metformin; Obesity; Insulin resistance;
The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice
Keywords: Ethanol; Alcoholism; Incretin hormones; Alcohol deprivation; Group-housed; Exenatide;
Exenatide Regulates Substrate Preferences Through the p38γ MAPK Pathway After Ischaemia/Reperfusion Injury in a Rat Heart
Keywords: Exenatide; p38 mitogen-activated protein kinases (MAPK); Ischaemia/reperfusion injury; Glucose transport proteins (GLUTs); FAT/CD36.;
Microbial expression of Exendin-4 analog and its efficacy in mice model
Keywords: Diabetes mellitus; Exendin-4; Exenatide; Hyperglycemia; Insulin;
Exenatide substantially improves proinsulin conversion and cell survival that augment Ins2+/Akita beta cell function
Keywords: Exenatide; Proinsulin maturation imperfections; Proinsulin conversion; Insulin secretion; Beta cell survival;
Exenatide-loaded microsphere/thermosensitive hydrogel long-acting delivery system with high drug bioactivity
Keywords: Exenatide; Peptide; Hydrogel; PLGA microspheres; Polymeric micelles;
Exenatide improves liver mitochondrial dysfunction and insulin resistance by reducing oxidative stress in high fat diet-induced obese mice
Keywords: Exenatide; Oxidative stress; Insulin resistance; Liver mitochondrial dysfunction; Obese mice; NAFLD; nonalcoholic fatty liver disease; GLP; Glucagon-like peptide; OGTT; Oral glucose tolerance tests; IPITT; intraperitoneal insulin tolerance tests; TC; Seru
The effects of GLP-1 based therapies on postprandial haemodynamics: Two randomised, placebo-controlled trials in overweight type 2 diabetes patients
Keywords: GLP-1 receptor agonist; Exenatide; Liraglutide; Heart rate; Haemodynamics; Sympathetic nervous system;
Cardiovascular side-effects and insulin secretion after intravenous administration of radiolabeled Exendin-4 in pigs
Keywords: Exenatide; Adverse-effects; Tachycardia; Arrhythmias; Swine; Imaging; PET; Monkeys;
Exenatide in obese or overweight patients without diabetes: A systematic review and meta-analyses of randomized controlled trials
Keywords: Exenatide; Obesity; Overweight; Body mass index; Meta-analysis;
Separation of mono- and di-PEGylate of exenatide and resolution of positional isomers of mono-PEGylates by preparative ion exchange chromatography
Keywords: Exenatide; Mono-PEGylation; Positional isomers; PEG-maleimide; Cation exchange chromatography; Peptide analogs
Early Pharmacodynamic Effects of Exenatide Once Weekly in Type 2 Diabetes Are Independent of Weight Loss: A Pooled Analysis of Patient-level Data
Keywords: diabetes mellitus; early response; exenatide; glucagon-like peptide-1 receptor agonist; HbA1c; pharmacokinetics;
Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatide
Keywords: Glucagon-like peptide-1; Exenatide; Adiponectin; Non-alcoholic fatty liver disease; Diabetes mellitus type 2;
Exenatide suppresses 1,2-dimethylhydrazine-induced colon cancer in diabetic mice: Effect on tumor angiogenesis and cell proliferation
Keywords: Diabetes mellitus; Colonic neoplasm; Exenatide; Inflammation; Angiogenesis; Cell proliferation
The effects of exenatide twice daily compared to insulin lispro added to basal insulin in Latin American patients with type 2 diabetes: A retrospective analysis of the 4B trial
Keywords: Exenatide; Insulin lispro; Type 2 diabetes; Latin America;
Neuropharmacology and analgesiaExenatide reduces TNF-α expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats
Keywords: Alzheimer's disease; Exenatide; Tumor necrosing factor-alpha; Choline acetyltransferase; Streptozotocin;
Synchrotron radiation-based Fourier-transform infrared spectromicroscopy for characterization of the protein/peptide distribution in single microspheres
Keywords: Fourier-transform infrared spectromicroscopy; Protein distribution; Microsphere; Exenatide; PLGA
Effects of the glucagon-like peptide-1 (GLP-1) analogues exenatide, exenatide extended-release, and of the dipeptidylpeptidase-4 (DPP-4) inhibitor sitagliptin on glucose metabolism in healthy cats
Keywords: MRT, meal response test; AUC, area under the curveIncretins; Cats; Diabetes mellitus; Exenatide; Sitagliptin
Comparative studies on exenatide-loaded poly (d,l-lactic-co-glycolic acid) microparticles prepared by a novel ultra-fine particle processing system and spray drying
Keywords: Ultra-fine particle processing system (UPPS); Spray drying; Microparticles; PLGA; Exenatide;
GLP-1 RAs as compared to prandial insulin after failure of basal insulin in type 2 diabetes: lessons from the 4B and Get-Goal DUO 2 trials
Keywords: GLP-1 receptor agonists; exenatide; lixisenatide; basal insulin
Pleiotropic effects of insulin and GLP-1 receptor agonists: Potential benefits of the association
Keywords: Exenatide; Liraglutide; Lixisenatide; NASH; Cardiovascular; Heart; Liver
Original ResearchOnce-Weekly Exenatide as Adjunct Treatment of Type 1 Diabetes Mellitus in Patients Receiving Continuous Subcutaneous Insulin Infusion Therapy
Keywords: exenatide; diabetes; glucagon-like peptide-1; incretin; exénatide; diabète; GLP-1 (glucagon-like peptide-1); incrétine;